Cargando…
Development of Lipid–Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin
Enoxaparin, an anticoagulant that helps prevent the formation of blood clots, is administered parenterally. Here, we report the development and evaluation of lipid–polymer hybrid nanoparticles (LPHNs) for the oral delivery of enoxaparin. The polymer poloxamer 407 (P407) was incorporated into lipid n...
Autores principales: | Tang, Bo, Qian, Yu, Fang, Guihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407632/ https://www.ncbi.nlm.nih.gov/pubmed/32629827 http://dx.doi.org/10.3390/pharmaceutics12070607 |
Ejemplares similares
-
Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability
por: Anwer, Md. Khalid, et al.
Publicado: (2021) -
Advanced delivery strategies facilitating oral absorption of heparins
por: Fang, Guihua, et al.
Publicado: (2020) -
Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization
por: Ebrahimian, Mahboubeh, et al.
Publicado: (2022) -
Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel
por: Qin, Lu, et al.
Publicado: (2021) -
Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD
por: Liang, Jun, et al.
Publicado: (2018)